The galactose elimination capacity test to monitor liver disease course in patients with Wilson’s disease

References

• Ala A, Walker AP, Ashkan K, et al. Wilson’s disease. The Lancet. 2007;369(9559):397–408.
   PubMed Web of Science ®Google Scholar
• Sandahl TD, Laursen TL, Munk DE, et al. The prevalence of Wilson's disease: an update. Hepatology. 2020;71(2):722–732.
   PubMed Web of Science ®Google Scholar
• Ferenci P, Caca K, Loudianos G, et al. Diagnosis and phenotypic classification of Wilson disease1. Liver Int. 2003;23(3):139–142.
   PubMed Web of Science ®Google Scholar
• Roberts EA, Schilsky ML, American Association for Study of Liver Diseases (AASLD) Diagnosis and treatment of wilson disease: an update. Hepatology. 2008;47(6):2089–2111.
   PubMed Web of Science ®Google Scholar
• European Association for the Study of the Liver. EASL clinical practice guidelines: Wilson’s disease. Journal of Hepatology. 2012;56:671–685.
   PubMed Web of Science ®Google Scholar
• Beinhardt S, Leiss W, Stättermayer AF, et al. Long-term outcomes of patients with Wilson disease in a large Austrian cohort. Clin Gastroenterol Hepatol. 2014;12(4):683–689.
   PubMed Web of Science ®Google Scholar
• Merle U, Schaefer M, Ferenci P, et al. Clinical presentation, diagnosis and long‐term outcome of Wilson’s disease: a cohort study. Gut. 2007;56(1):115–120.
   PubMed Web of Science ®Google Scholar
• Weiss KH, Gotthardt DN, Klemm D, et al. Zinc monotherapy is not as effective as chelating agents in treatment of Wilson disease. Gastroenterology. 2011;140(4):1189–1198.e1.
   PubMed Web of Science ®Google Scholar
• Masełbas W, Chabik G, Członkowska A. Persistence with treatment in patients with wilson disease. Neurologia i Neurochirurgia Polska. 2010;44(3):260–263.
   PubMed Web of Science ®Google Scholar
• Członkowska A, Tarnacka B, Möller JC, et al. Unified Wilson’s disease rating scale - a proposal for the neurological scoring of Wilson’s disease patients. Neurol Neurochir Pol. 2007;41(1):1–12.
   PubMed Web of Science ®Google Scholar
• Aggarwal A, Aggarwal N, Nagral A, et al. A novel global assessment scale for Wilson's disease (GAS for WD)). Mov Disord. 2009;24(4):509–518.
   PubMed Web of Science ®Google Scholar
• Volpert HM, Pfeiffenberger J, Gröner JB, et al. Comparative assessment of clinical rating scales in Wilson’s disease. BMC Neurol. 2017;17(1):140.
   PubMed Web of Science ®Google Scholar
• Benedeto-Stojanov D, Nagorni A, Bjelaković G, et al. The model for the end-stage liver disease and Child-Pugh score in predicting prognosis in patients with liver cirrhosis and esophageal variceal bleeding. VSP. 2009;66(9):724–728.
   Google Scholar
• Nazer H, Ede RJ, Mowat AP, et al. Wilson's disease: clinical presentation and use of prognostic index. Gut. 1986;27(11):1377–1381.
   PubMed Web of Science ®Google Scholar
• Dhawan A, Taylor RM, Cheeseman P, et al. Wilson’s disease in children: 37-year experience and revised king’s score for liver transplantation. Liver Transpl. 2005;11(4):441–448.
   PubMed Web of Science ®Google Scholar
• Pfeiffenberger J, Lohse CM, Gotthardt D, et al. Long-term evaluation of urinary copper excretion and non-caeruloplasmin associated copper in Wilson disease patients under medical treatment. J Inherit Metab Dis. 2019;42(2):371–380.
   PubMed Web of Science ®Google Scholar
• Jepsen P, Vilstrup H, Ott P, et al. The galactose elimination capacity and mortality in 781 Danish patients with newly-diagnosed liver cirrhosis: a cohort study. BMC Gastroenterol. 2009;9(1):50.
   PubMed Web of Science ®Google Scholar
• Ranek L, Andreasen PB, Tygstrup N. Galactose elimination capacity as a prognostic index in patients with fulminant liver failure. Gut. 1976;17(12):959–964.
   PubMed Web of Science ®Google Scholar
• Björklund J, Laursen TL, Sandahl TD, et al. High hepatic macrophage activation and low liver function in stable Wilson patients - a Danish cross-sectional study. Orphanet J Rare Dis. 2018;13(1):169.
   PubMed Web of Science ®Google Scholar
• Tygstrup N. The galactose elimination capacity in control subjects and in patients with cirrhosis of the liver. Acta Med Scand. 1964;175:281–289.
   PubMedGoogle Scholar
• EASL-ALEH clinical practice guidelines: non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol. 2015;63:237–264.
   PubMed Web of Science ®Google Scholar
• Harris PA, Taylor R, Minor BL, REDCap Consortium, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform. 2019;95:103208.
   PubMed Web of Science ®Google Scholar
• Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–381.
   PubMed Web of Science ®Google Scholar
• Brewer GJ, Dick RD, Johnson VD, et al. Treatment of Wilson’s disease with zinc: XV long-term follow-up studies. J Lab Clin Med. 1998;132(4):264–278.
   PubMed Web of Science ®Google Scholar
• Iorio R, D'Ambrosi M, Marcellini M, Hepatology Committee of Italian Society of Paediatric Gastroenterology Hepatology and Nutrition, et al. Serum transaminases in children with Wilson’s disease. J Pediatr Gastroenterol Nutr. 2004;39(4):331–336.
   PubMed Web of Science ®Google Scholar
• Karlas T, Hempel M, Tröltzsch M, et al. Non-invasive evaluation of hepatic manifestation in Wilson disease with transient elastography, ARFI, and different fibrosis scores. Scandinavian J Gastroenterol. 2012;47(11):1353–1361.
   PubMed Web of Science ®Google Scholar
• Sini M, Sorbello O, Civolani A, et al. Non-invasive assessment of hepatic fibrosis in a series of patients with Wilson's disease. Dig Liver Dis. 2012;44(6):487–491.
   PubMedGoogle Scholar
• Castéra L, Foucher J, Bernard P-H, et al. Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations. Hepatology. 2010;51(3):828–835.
   PubMed Web of Science ®Google Scholar